• Mashup Score: 4

    In the post-acute phase, we report increased risks and 12-month burdens of incident diabetes and antihyperglycaemic use in people with COVID-19 compared with a contemporary control group of people who were enrolled during the same period and had not contracted SARS-CoV-2, and a historical control group from a pre-pandemic era. Post-acute COVID-19 care should involve identification and management…

    Tweet Tweets with this article
    • No.2 in our #MostRead: Risks and burdens of incident #diabetes in long #COVID: a cohort study https://t.co/xWdiowxg9e #LongCovid #COVID19 #FREE to read https://t.co/nIVSD5ifU6